4//SEC Filing
Reape Kathleen 4
Accession 0001209191-20-060225
CIK 0001806310other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:41 PM ET
Size
5.3 KB
Accession
0001209191-20-060225
Insider Transaction Report
Form 4
Reape Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-23+31,000→ 31,000 totalExercise: $21.77Exp: 2030-11-23→ Common Stock (31,000 underlying)
Footnotes (1)
- [F1]The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001832203
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:41 PM ET
- Size
- 5.3 KB